CRP and COVID-19: In COVID-19 patients with a secondary outcome, all investigated inflammatory biomarkers were significantly higher compared to event-free survivors, e.g., CRP 112.1 mg/l (IQR 47.6–162.0) vs. 15.1 mg/l (IQR 1.6–46.5), p<0.001 (S3 Table).